EP0162: A Double-blind, Randomized, Placebo-controled, Multicenter, Outpatient, Parallel-group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Grants and Contracts Details

StatusActive
Effective start/end date6/20/236/20/25

Funding

  • UCB Pharma (domestic): $8,431.00